← All trials
NCT05773703
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 8, 2022
- Primary completion
- Dec 12, 2023
- Completion date
- Dec 12, 2023
- First posted
- Mar 17, 2023
- Last posted
- Dec 13, 2023
- Enrollment
- 23
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Ratio Therapeutics, Inc.Lead sponsor
- Ratio Therapeutics, Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.